atherosclerosis therapy (Rhone-Poulenc Rorer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameatherosclerosis therapy (Rhone-Poulenc Rorer)
Drug Alias NameATP-binding cassette transporter-1 (ABC-1) gene (Rhone-Poulenc Rorer/NIH/Munster)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL cholesterol modulators
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhone Poulenc Rorer Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A